NKGen Biotech (NKGN) announced the administration of troculeucel, an expanded autologous NK cell therapy, in an FTD patient under a single ...
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback